(Q36821488)

16 August 2017

1 reference

title

New insights into central nervous system lupus: a clinical perspective (English)

1 reference

16 August 2017

John G Hanly

1

1 reference

16 August 2017

1 May 2007

1 reference

Current Rheumatology Reports

16 August 2017

1 reference

16 August 2017

9

1 reference

16 August 2017

2

1 reference

16 August 2017

116-124

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-007-0005-2

16 August 2017

0 references

cites work

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0005-2

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0005-2

Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

1 reference

12 December 2020

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

1 reference

12 December 2020

The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

1 reference

12 December 2020

Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.

1 reference

12 December 2020

Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers.

1 reference

12 December 2020

Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

12 December 2020

Cognition and immunity; antibody impairs memory

1 reference

12 December 2020

Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

1 reference

12 December 2020

Cognitive disorders in systemic lupus erythematosus. Epidemiologic and clinical issues

1 reference

12 December 2020

Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.

1 reference

12 December 2020

Neuropsychiatric lupus

1 reference

12 December 2020

Results of intervention for lupus patients with self-perceived cognitive difficulties.

1 reference

12 December 2020

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

1 reference

12 December 2020

Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

1 reference

12 December 2020

Clinical course of cognitive dysfunction in systemic lupus erythematosus.

1 reference

12 December 2020

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort

1 reference

12 December 2020

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

12 December 2020

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

1 reference

12 December 2020

Management of neuropsychiatric lupus

1 reference

12 December 2020

Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide

1 reference

12 December 2020

Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors

1 reference

12 December 2020

Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus.

1 reference

12 December 2020

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

1 reference

12 December 2020

A Controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus

1 reference

12 December 2020

Methylprednisolone pulse therapy for nonrenal lupus erythematosus

1 reference

12 December 2020

Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

1 reference

12 December 2020

Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality

1 reference

12 December 2020

Evaluation of patients with CNS involvement in SLE.

1 reference

12 December 2020

Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation.

1 reference

12 December 2020

Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study

1 reference

12 December 2020

Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus

1 reference

12 December 2020

Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.

1 reference

12 December 2020

Neuroimaging in neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.

1 reference

12 December 2020

Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement

1 reference

12 December 2020

Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study

1 reference

12 December 2020

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Central nervous system involvement in the antiphospholipid (Hughes) syndrome

1 reference

12 December 2020

Interferon-alpha in lupus psychosis

1 reference

12 December 2020

Neuropsychiatric lupus

1 reference

12 December 2020

10.1007/S11926-007-0005-2

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17502041